Fiduciary Family Office LLC lowered its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 12.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,645 shares of the enterprise software provider's stock after selling 2,352 shares during the period. Oracle makes up approximately 1.2% of Fiduciary Family Office LLC's holdings, making the stock its 13th largest holding. Fiduciary Family Office LLC's holdings in Oracle were worth $3,639,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of ORCL. Brighton Jones LLC grew its stake in shares of Oracle by 189.3% in the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock worth $25,593,000 after purchasing an additional 100,494 shares during the last quarter. Revolve Wealth Partners LLC grew its stake in shares of Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock worth $903,000 after purchasing an additional 404 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Oracle by 8.1% in the first quarter. GAMMA Investing LLC now owns 34,011 shares of the enterprise software provider's stock worth $4,755,000 after purchasing an additional 2,546 shares during the last quarter. Advisor Resource Council bought a new stake in shares of Oracle in the first quarter worth about $328,000. Finally, Inlight Wealth Management LLC bought a new stake in shares of Oracle in the first quarter worth about $28,000. 42.44% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, Director Naomi O. Seligman sold 2,222 shares of the business's stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total value of $641,958.02. Following the completion of the transaction, the director directly owned 29,225 shares in the company, valued at $8,443,394.75. The trade was a 7.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the business's stock in a transaction that occurred on Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares of the company's stock, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,769 shares of company stock worth $36,428,967 over the last 90 days. 40.90% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on ORCL shares. BMO Capital Markets set a $355.00 target price on Oracle and gave the stock an "outperform" rating in a research note on Monday, October 13th. Stephens raised their target price on Oracle from $208.00 to $331.00 and gave the stock an "equal weight" rating in a research note on Friday. UBS Group raised their target price on Oracle from $360.00 to $380.00 and gave the stock a "buy" rating in a research note on Friday. Guggenheim lifted their price objective on Oracle from $375.00 to $400.00 and gave the company a "buy" rating in a research report on Friday. Finally, Citigroup reaffirmed a "buy" rating on shares of Oracle in a research report on Friday, October 10th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, Oracle currently has a consensus rating of "Moderate Buy" and a consensus target price of $323.69.
Read Our Latest Stock Analysis on ORCL
Oracle Stock Performance
Shares of ORCL opened at $276.93 on Tuesday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The business's 50 day moving average price is $272.19 and its 200-day moving average price is $217.44. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72. The stock has a market cap of $789.47 billion, a P/E ratio of 64.10, a P/E/G ratio of 3.14 and a beta of 1.53.
Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion during the quarter, compared to the consensus estimate of $15.04 billion. During the same period in the prior year, the firm earned $1.39 earnings per share. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle's payout ratio is presently 46.30%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.